Granules India is currently trading at Rs. 121.50, up by 6.10 points or 5.29% from its previous closing of Rs. 115.40 on the BSE.
The scrip opened at Rs. 119.60 and has touched a high and low of Rs. 123.00 and Rs. 119.50 respectively. So far 1,28,000 shares were traded on the counter.
The BSE group 'B' stock of face value Rs. 1 has touched a 52 week high of Rs. 134.00 on 20-Aug-2015 and a 52 week low of Rs. 70.82 on 16-Dec-2014.
Last one week high and low of the scrip stood at Rs. 123.00 and Rs. 114.20 respectively. The current market cap of the company is Rs. 2,483.00 crore.
The promoters holding in the company stood at 48.47% while Institutions and Non-Institutions held 3.05% and 48.48% respectively.
Granules India has received USFDA approval for its Abbreviated New Drug Applications (ANDA) for Ibuprofen Tablets USP, 400 mg, 600 mg and 800 mg.
Granules India is a fast growing pharmaceutical manufacturing company with world class facilities and is committed to manufacturing excellence, quality and customer service. The Company produces Finished Dosages (FDs), Pharmaceutical Formulation Intermediates (PFIs) and Active Pharmaceutical Ingredients (APIs) for quality conscious customers in the regulated and semi-regulated markets.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1786.05 |
Dr. Reddys Lab | 1354.20 |
Cipla | 1470.05 |
Lupin | 2190.50 |
Zydus Lifesciences | 1004.05 |
View more.. |